Sequenom Inc. to Present at Leerink Swann and Company/MEDACorp Roundtable Conference

SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ: SQNM) today announced that Harry Stylli, Ph.D., President and Chief Executive Officer, is scheduled to present at the Leerink Swann & Company/MEDACorp Emerging Products and Applications of Life Science Tools Roundtable Conference on Thursday, August 9 at 10:30 a.m. Eastern time (7:30 a.m. Pacific time). Dr. Stylli also will participate on the “Emerging Products and Applications for Medium Density Arrays” panel discussion hosted by Leerink Swann’s Managing Director, Life Science Equity Research John L. Sullivan. The conference is being held at the Le Parker Meridien Hotel in New York City.